Email Address:
  
  Password:
  
  

EXHIBIT 10.1

CLINICAL TRIAL MANUFACTURING AGREEMENT

This Clinical Trial Manufacturing Agreement   ( “Agreement” )   dated this   30th day of October,   2006 (the “Effective Date” ) between:          

 

SWISS CAPS AG , of Husenstr. 35, CH-9533 Kirchberg, Switzerland ( “Swiss Caps” ) – Fax +41 (0)71 931 41 91

And

ORAMED PHARMACEUTICALS, INC. , of 2 Elza Street, Jerusalem, 93706, Israel ( “Oramed” or the “Company” ) –Fax +011 972-2-679-2336

WITNESSES THAT WHEREAS

A.      

Swiss Caps is a manufacturer and business development services partner for the pharmaceutical and healthcare industry;

 

B.      

Oramed is in the business of developing an oral form of insulin; and

 

C.      

Oramed desires to engage the services of Swiss Caps, and Swiss Caps accepts such appointment, to manufacture and deliver the Product (as defined below) to Oramed in accordance with the terms and conditions of this Agreement.

 

NOW THEREFORE, in consideration of the premises and the covenants and agreements set out herein, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1.      

DEFINITIONS & INTERPRETATION

 

1.1      

All capitalised terms in this Agreement have the following meaning:

 

 

(a)      

Agreement ” means this agreement for services and includes its schedules and any documents incorporated by reference, as amended from time to time in accordance with its terms.

 

 

(b)      

Compensation ” means the compensation for the Services as set out in the Statement of Work.

 

 

(c)      

Force Majeure Event ” means any act of God or act of nature, fire, flood, storm, explosion, sabotage, riot, act of war whether declared or not, act of terrorism, requirement or restriction of governmental authorities, inability or delay in the grant of governmental or other approvals, consents, permits, licenses or authorities or any other like event, any strike, lockout, work stoppage or other industrial dispute of any kind, or any other event or circumstance beyond the reasonable control of the affected party.

 

CW638406.16


- 2 -

(d)      

Intellectual Property ” means all inventions, methods, processes, ideas and concepts, whether patentable or not, all literary and other works and all data and databases, whether or not protected by copyright, all trade-marks, trade names and domain names, industrial designs, integrated circuit topographies, trade secrets, know-how and show-how.

 

(e)      

Intellectual Property Rights ” means all world-wide legal protection provided for Intellectual Property, whether under statute, common law, international treaty or in equity, including all protection granted under laws protecting patent, copyright, trade-mark, industrial design, trade secret or integrated circuit topography rights.

 

(f)      

Loss ” means all costs, loss, damage, liability or expenses (including all reasonable legal costs, fees and expenses).

 

(g)      

Oramed Confidential Information ” means all confidential information of Oramed including all Oramed Materials, all know-how, trade secrets, business ideas and concepts of Oramed, all technical, operational, strategic, marketing, financial and business information relating to Oramed, all Intellectual Property of Oramed and any formulas, reports, notes, medical records, test results, patient information and any other information or data provided to Swiss Caps by Oramed that is designated in writing as confidential or that Swiss Caps ought to be reasonably aware is confidential. Oramed Confidential Information does not include information which is: (i) made public other than by a breach of an obligation of confidentiality, (ii) disclosed to Swiss Caps free of any obligation to keep it confidential, or (iii) independently developed by Swiss Caps without use, directly or indirectly, of Oramed Confidential Information received from Oramed.

 

(h)      

Oramed Materials ” means all materials provided by Oramed to Swiss Caps in order to assist Swiss Caps with the provision of the Services including, without limitation, those listed on Schedule 1 attached to this Agreement.

 

(i)      

Personnel ” means directors, officers, employees, agents, contractors, advisers or representatives of a party.

 

(j)      

Primary Contact ” has the meaning given to that term in Section 4.1 of this Agreement.

 

(k)      

Product ” means the product developed as a result of the provision of the Services in accordance with the Specifications, as detailed in the Statement of Work.

 

(l)      

Representatives ” has the meaning given to that term in Section 15.4(b) of this Agreement.

 

(m)      

Services ” means the services which Swiss Caps has agreed to supply to Oramed as detailed in the Statement of Work.

 

CW638406.16


- 3 -

(n)      

Specifications ” means the technical specifications for the Product, as specified in the Statement of Work.

 

(o)      

Swiss Caps Confidential Information ” means all confidential information of Swiss Caps including all know-how, trade secrets, business ideas and concepts of Swiss Caps, all technical, operational, strategic, marketing, financial and business information relating to Swiss Caps, all Intellectual Property of Swiss Caps and any other information or data provided to Oramed by Swiss Caps that is designated in writing as confidential or that Oramed ought to be reasonably aware is confidential. Swiss Caps Confidential Information does not include information which is: (i) made public other than by a breach of an obligation of confidentiality, (ii) disclosed to Oramed free of any obligation to keep it confidential, or (iii) independently developed by Oramed without use, directly or indirectly, of Swiss Caps Confidential Information received from Swiss Caps.

 

(p)      

Statement of Work ” means the statement of work attached as Schedule 1 to this Agreement, setting out the Services, the Product, the Specifications and the Compensation, as amended by the parties from time-to-time in accordance with the terms of this Agreement.

 

(q)      

Term ” has the meaning given to that term in Section 3.1 of this Agreement.

 

 

1.2      

All references to any Section herein is to the Section in this Agreement unless otherwise specified. All references to a Schedule herein is to a Schedule of this Agreement unless otherwise specified.

 

1.3      

The headings in this Agreement are for reference purposes only and will not be deemed a part of the Agreement.

 

1.4      

The term “including” means including without limitation or prejudice to the generality of any description, definition, term or phrase preceding that word, and the word “include” and its derivatives will be construed accordingly.

 

1.5      

The interpretation of any ambiguities will be construed by the principles of fairness and reasonable business practice, and authorship of this Agreement will have no bearing on the construction of any terms hereof.

 

2.      

APPOINTMENT

 

2.1      

Swiss Caps hereby agrees to perform for Oramed and Oramed hereby engages Swiss Caps to perform the Services in accordance with the terms and conditions of this Agreement.

 

2.2      

The parties agree and acknowledge that:

 

 

(a)      

the manufacturing of the Product under this Agreement is for clinical testing purposes (proof of concept) only; and

 

CW638406.16


- 4 -

(b)      

should Oramed elect to engage Swiss Caps to manufacture the Product for commercial distribution, a separate agreement will be entered into by the parties for such purpose.

 

 

3.      

TERM

 

3.1      

Subject to the express termination rights granted herein, this Agreement will commence on the Effective Date and will remain in full force and effect for a period of six (6) months from the Effective Date (the “ Term ”). The parties may renew this Agreement by mutual consent.

 

4.      

PRIMARY CONTACTS

 

4.1      

Upon execution of this Agreement, each party will designate a primary contact (“ Primary Contact ”) who will have the primary responsibility for that party’s relationship with the other party and will have the authority necessary to make the day-to- day decisions on behalf of that party with respect to the implementation of this Agreement.

 

5.      

SERVICES

 

5.1      

Swiss Caps will perform the Services in accordance with the terms of this Agreement and otherwise in a professional and workmanlike manner in accordance with industry best practices and using only appropriately skilled and experienced personnel exercising due care at all times.

 

5.2      

Swiss Caps will commence performing the Services on the Effective Date and will use best commercial efforts to meet the milestones and target dates (if any) specified in the Statement of Work.

 

5.3      

Oramed will, promptly after the Effective Date, deliver to Swiss Caps the Oramed Materials necessary for Swiss Caps to fulfil its obligations herein.

 

5.4      

Oramed will ship the Oramed Materials to Swiss Caps Delivered Duty Paid (DDP) (Incoterms 2000), and Swiss Caps will be responsible for insuring against loss or damage while the Oramed Materials are in the custody, possession or control of Swiss Caps, as required by Section 13.

 

5.5      

Notwithstanding the above clause, Swiss Caps is responsible to provide, at its cost, all materials necessary to carry out the terms of this Agreement and provide the Services and the Product.

 

5.6      

Swiss Caps will ship the Product, FCA Kirchberg (Incoterms 2000), to Oramed’s nominated address promptly on completion of the Services.

 

CW638406.16


- 5 -

6.      

AMENDMENT TO STATEMENT OF WORK

 

6.1      

If the parties jointly determine that the scope of the Services being provided under the Statement of Work, or the assumptions on which those Services are based, has changed during the course of the engagement, then such changes will be described in a written change order (“ Change Order ”) to be signed by both parties. At the option of Oramed, such additional Services may be addressed in a separate Statement of Work signed by both parties.

 

6.2      

If Oramed wishes at any time to request a change in the Services specified in the Statement of Work, then it will prepare a Change Order. Swiss Caps will evaluate and respond to any change request within 20 business days or such other period as the parties may agree in writing. Swiss Caps’ response will include the amount of any adjustment to the Compensation, if any, and an estimate on any perceived changes to the delivery dates, if applicable, specified for the Product in light of the change to the scope of the Services.

 

 

Upon receiving written authorization from Oramed, Swiss Caps will proceed with Oramed’s requested changes and the Statement of Work will be deemed to be amended accordingly.

 

7.      

ORAMED WARRANTIES

 

7.1      

Oramed represents and warrants that


This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more